Moderna secures $50m to fast-track mRNA Ebola vaccine development
The Coalition for Epidemic Preparedness Innovations is investing $50 million in Moderna’s mRNA platform to develop a vaccine against the deadly Bundibugyo ebolavirus strain spreading in the Democratic Republic of the Congo.